消除埃塞俄比亚淋巴丝虫病国家计划。

Q3 Medicine
Ethiopian Medical Journal Pub Date : 2017-01-01
Belete Mengistu, Kebede Deribe, Fikreab Kebede, Sarah Martindale, Mohammed Hassan, Heven Sime, Charles Mackenzie, Abate Mulugeta, Mossie Tamiru, Mesfin Sileshi, Asrat Hailu, Teshome Gebre, Amha Fentaye, Biruck Kebede
{"title":"消除埃塞俄比亚淋巴丝虫病国家计划。","authors":"Belete Mengistu, Kebede Deribe, Fikreab Kebede, Sarah Martindale, Mohammed Hassan, Heven Sime, Charles Mackenzie, Abate Mulugeta, Mossie Tamiru, Mesfin Sileshi, Asrat Hailu, Teshome Gebre, Amha Fentaye, Biruck Kebede","doi":"","DOIUrl":null,"url":null,"abstract":"<p><p>Lymphatic filariasis (LF) is one of the most debilitating and disfiguring diseases common in Ethiopia and is caused by Wuchereria bancrofti. Mapping for LF has shown that 70 woredas (districts) are endemic and 5.9 million people are estimated to be at risk. The national government's LF elimination programme commenced in 2009 in 5 districts integrated with the onchocerciasis programme. The programme developed gradually and has shown significant progress over the past 6 years, reaching 100% geographical coverage for mass drug administration (MDA) by 2016. To comply with the global LF elimination goals an integrated morbidity management and disability prevention (MMDP) guideline and a burden assessment programme has also been developed; MMDP protocols and a hydrocoele surgical handbook produced for country-wide use. In Ethiopia, almost all LF endemic districts are co-endemic with malaria and vector control aspects of the activities are conducted in the context of malaria programme as the vectors for both diseases are mosquitoes. In order to monitor the elimination, 11 sentinel and spot-check sites have been established and baseline information has been collected. Although significant achievements have been achieved in the scale up of the LF elimination programme, there is still a need to strengthen operational research to generate programme-relevant evidence, to increase access to morbidity management services, and to improve monitoring and evaluation of the LF programme. However, the current status of implementation of the LF national programme indicates that Ethiopia is poised to achieve the 2020 goal of elimination of LF. Nevertheless, to achieve this goal, high and sustained treatment coverage and strong monitoring and evaluation of the programme are essential.</p>","PeriodicalId":11937,"journal":{"name":"Ethiopian Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582637/pdf/emss-73812.pdf","citationCount":"0","resultStr":"{\"title\":\"The National Programme to Eliminate Lymphatic Filariasis from Ethiopia.\",\"authors\":\"Belete Mengistu, Kebede Deribe, Fikreab Kebede, Sarah Martindale, Mohammed Hassan, Heven Sime, Charles Mackenzie, Abate Mulugeta, Mossie Tamiru, Mesfin Sileshi, Asrat Hailu, Teshome Gebre, Amha Fentaye, Biruck Kebede\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Lymphatic filariasis (LF) is one of the most debilitating and disfiguring diseases common in Ethiopia and is caused by Wuchereria bancrofti. Mapping for LF has shown that 70 woredas (districts) are endemic and 5.9 million people are estimated to be at risk. The national government's LF elimination programme commenced in 2009 in 5 districts integrated with the onchocerciasis programme. The programme developed gradually and has shown significant progress over the past 6 years, reaching 100% geographical coverage for mass drug administration (MDA) by 2016. To comply with the global LF elimination goals an integrated morbidity management and disability prevention (MMDP) guideline and a burden assessment programme has also been developed; MMDP protocols and a hydrocoele surgical handbook produced for country-wide use. In Ethiopia, almost all LF endemic districts are co-endemic with malaria and vector control aspects of the activities are conducted in the context of malaria programme as the vectors for both diseases are mosquitoes. In order to monitor the elimination, 11 sentinel and spot-check sites have been established and baseline information has been collected. Although significant achievements have been achieved in the scale up of the LF elimination programme, there is still a need to strengthen operational research to generate programme-relevant evidence, to increase access to morbidity management services, and to improve monitoring and evaluation of the LF programme. However, the current status of implementation of the LF national programme indicates that Ethiopia is poised to achieve the 2020 goal of elimination of LF. Nevertheless, to achieve this goal, high and sustained treatment coverage and strong monitoring and evaluation of the programme are essential.</p>\",\"PeriodicalId\":11937,\"journal\":{\"name\":\"Ethiopian Medical Journal\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5582637/pdf/emss-73812.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ethiopian Medical Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ethiopian Medical Journal","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

淋巴丝虫病(LF)是由班克罗夫蒂绦虫(Wuchereria bancrofti)引起的埃塞俄比亚最常见的致残和毁容疾病之一。对淋巴丝虫病的摸底调查显示,有 70 个县(区)的淋巴丝虫病流行,估计有 590 万人受到威胁。2009 年,国家政府在 5 个地区启动了消除 LF 计划,该计划与盘尾丝虫病计划相结合。该计划逐步发展,在过去 6 年中取得了显著进展,到 2016 年,大规模药物管理(MDA)的地域覆盖率达到 100%。为实现全球消除淋巴结核的目标,还制定了综合发病率管理和残疾预防(MMDP)准则和负担评估计划;并编制了MMDP规程和水牛症手术手册,供全国使用。在埃塞俄比亚,几乎所有 LF 流行区都是疟疾的共同流行区,由于这两种疾病的病媒都 是蚊子,因此病媒控制方面的活动都是在疟疾计划的背景下开展的。为了监测消灭疟疾的情况,已经建立了 11 个哨点和抽查点,并收集了基线信息。尽管在扩大消除 LF 计划的规模方面取得了重大成就,但仍有必要加强业务研究,以提 供与计划相关的证据,增加获得发病率管理服务的机会,并改进对 LF 计划的监测和评 估。然而,LF 国家计划的实施现状表明,埃塞俄比亚有望实现 2020 年消除 LF 的目标。然而,要实现这一目标,持续的高治疗覆盖率以及对计划的有力监测和评估至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

The National Programme to Eliminate Lymphatic Filariasis from Ethiopia.

The National Programme to Eliminate Lymphatic Filariasis from Ethiopia.

The National Programme to Eliminate Lymphatic Filariasis from Ethiopia.

Lymphatic filariasis (LF) is one of the most debilitating and disfiguring diseases common in Ethiopia and is caused by Wuchereria bancrofti. Mapping for LF has shown that 70 woredas (districts) are endemic and 5.9 million people are estimated to be at risk. The national government's LF elimination programme commenced in 2009 in 5 districts integrated with the onchocerciasis programme. The programme developed gradually and has shown significant progress over the past 6 years, reaching 100% geographical coverage for mass drug administration (MDA) by 2016. To comply with the global LF elimination goals an integrated morbidity management and disability prevention (MMDP) guideline and a burden assessment programme has also been developed; MMDP protocols and a hydrocoele surgical handbook produced for country-wide use. In Ethiopia, almost all LF endemic districts are co-endemic with malaria and vector control aspects of the activities are conducted in the context of malaria programme as the vectors for both diseases are mosquitoes. In order to monitor the elimination, 11 sentinel and spot-check sites have been established and baseline information has been collected. Although significant achievements have been achieved in the scale up of the LF elimination programme, there is still a need to strengthen operational research to generate programme-relevant evidence, to increase access to morbidity management services, and to improve monitoring and evaluation of the LF programme. However, the current status of implementation of the LF national programme indicates that Ethiopia is poised to achieve the 2020 goal of elimination of LF. Nevertheless, to achieve this goal, high and sustained treatment coverage and strong monitoring and evaluation of the programme are essential.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Ethiopian Medical Journal
Ethiopian Medical Journal Medicine-Medicine (all)
CiteScore
0.40
自引率
0.00%
发文量
0
期刊介绍: The Ethiopian Medical Journal (EMJ) is the official Journal of the Ethiopian Medical Association (EMA) and devoted to the advancement and dissemination of knowledge pertaining to the broad field of medicine in Ethiopia and other developing countries. Prospective contributors to the Journal should take note of the instructions of Manuscript preparation and submission to EMJ as outlined below.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信